Sernova (SEOVF) Stock Price, News & Analysis

Company Overview

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

Key Stats

• Today's Range: $0.14 to $0.15
• 50-Day Range: $0.13 to $0.18
• 52-Week Range: $0.12 to $0.51
• Volume: 17,750 shs
• Average Volume: 24,110 shs
• Market Capitalization: $46.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.50
• Consensus Rating: Hold

Sernova Stock Analysis - MarketRank™

Sernova scored higher than 56% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Sernova has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Sernova has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sernova is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sernova is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.05% of the outstanding shares of Sernova have been sold short.

Short Interest Ratio / Days to Cover

Sernova has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sernova has recently decreased by 20.31%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sernova does not currently pay a dividend.

Dividend Growth

Sernova does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.05% of the outstanding shares of Sernova have been sold short.

Short Interest Ratio / Days to Cover

Sernova has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Sernova has recently decreased by 20.31%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: N/A

News Sentiment

Sernova has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Sernova this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sernova insiders have not sold or bought any company stock.

SEOVF Stock Analysis - Frequently Asked Questions

How have SEOVF shares performed this year?

Sernova's stock was trading at $0.15 at the beginning of the year. Since then, SEOVF stock has decreased by 5.3% and is now trading at $0.1420.
View the best growth stocks for 2025 here.

How were Sernova's earnings last quarter?

Sernova Corp. (OTCMKTS:SEOVF) issued its earnings results on Monday, December, 23rd. The company reported ($0.01) EPS for the quarter.

How do I buy shares of Sernova?

Shares of SEOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 12/23/2024
• Today: 2/01/2025
• Next Earnings (Estimated): 3/17/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:SEOVF
• CUSIP: N/A
• CIK: 1491434
• Web: www.sernova.com
• Phone: (519) 858-5184
• Fax: 519-858-5184
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $1.50
• High Stock Price Target: $1.50
• Low Stock Price Target: $1.50
• Potential Upside/Downside: +956.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.06)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-23,650,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -479.95%
• Return on Assets: -283.67%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.32
• Quick Ratio: 0.32

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -4.73

Miscellaneous

• Outstanding Shares: 328,480,000
• Free Float: N/A
• Market Cap: $46.64 million
• Optionable: Not Optionable
• Beta: 1.17